Proposed LCD DL40238: MolDX: Genetic Testing for Hereditary Thrombophilia — Palmetto GBA
Policy LCD-DL40238 · Hematology
Impact on billing for hereditary thrombophilia testing.
Code intelligence
D68.52 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code D68.52.
Elevated code riskView ICD-10 detail
Signal breakdown
5 shown · 5 total in platform
Risk: Elevated
0
Critical
0%
5
High
100%
0
Routine
0%
0
Low
0%
New this month
+4
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L40274: MolDX: Genetic Testing for Hereditary Thrombophilia — WPS
Policy LCD-L40274 · Clinical Laboratory
WPS final LCD for hereditary thrombophilia genetic testing, eff. 10/12/2026
LCD L40242: MolDX: Genetic Testing for Hereditary Thrombophilia — Noridian
Policy LCD-L40242 · Clinical Laboratory
Noridian finalizes hereditary thrombophilia genetic test coverage 10/12/2026
LCD L40238: MolDX: Genetic Testing for Hereditary Thrombophilia — Palmetto GBA
Policy LCD-L40238 · Clinical Laboratory
Palmetto GBA finalizes hereditary thrombophilia genetic testing coverage Oct 202
LCD L40259: MolDX: Genetic Testing for Hereditary Thrombophilia — CGS
Policy LCD-L40259 · Clinical Laboratory
CGS MolDX hereditary thrombophilia genetic testing LCD effective Oct 2026
Audit documentation
Building an audit file that includes D68.52?
The Tripwire Audit Pack exports 12 months of Hematology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Hematology audit pack — $349One-time purchase · not a subscription